Charles Witherspoon - 31 Oct 2023 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP & Treasurer
Signature
/s/ Luis Cantarero
Issuer symbol
WST
Transactions as of
31 Oct 2023
Net transactions value
-$117,254
Form type
4
Filing time
02 Nov 2023, 13:37:17 UTC
Previous filing
11 Aug 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $102,893 +594 +32% $173.22 2,429 31 Oct 2023 Direct
transaction WST Common Stock Options Exercise $163,477 +596 +25% $274.29 3,025 31 Oct 2023 Direct
transaction WST Common Stock Sale $191,550 -594 -20% $322.48 2,431 31 Oct 2023 Direct
transaction WST Common Stock Sale $192,073 -596 -25% $322.27 1,835 31 Oct 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to Buy) Options Exercise $0 -594 -55% $0.000000 478 31 Oct 2023 Stock Options (Right to Buy) 594 $173.22 Direct F1
transaction WST Stock Options (Right to Buy) Options Exercise $0 -596 -50% $0.000000 596 31 Oct 2023 Stock Options (Right to Buy) 596 $274.29 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in four equal annual installments beginning on February 18, 2021.
F2 This award vests in four equal annual installments beginning on February 23, 2022.